Investors watchful Oversold Stock: KEMET Corporation stock RSI shifts below 30

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] Investors watchful Oversold Stock: KEMET Corporation stock RSI shifts below 30 [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]KEMET Corporation (KEM) stock go up so far this year; showing a rise of 274.36% and dropped with negative... Read more »

Keep Juno Therapeutics, Inc. (JUNO) stock under observation

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] Keep Juno Therapeutics, Inc. (JUNO) stock under observation [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]Technical analysis of Juno Therapeutics, Inc. (JUNO) stock Technical analysis is taken considering latest data in today current trading session.... Read more »

Snap Inc Spectacles Flop Is a Symptom of a Way Bigger Problem

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] Snap Inc Spectacles Flop Is a Symptom of a Way Bigger Problem Consumer response was symptomatic of what is wrong at Snap [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]Bad news for Snap Inc (NYSE:SNAP), and by... Read more »

ROKU stock has pulled back from post-IPO highs, but it still isn’t cheap

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] The 3 Key Problems Facing Roku Inc Stock ROKU stock has pulled back from post-IPO highs, but it still isn’t cheap [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]Roku Inc (NASDAQ:ROKU) stock has lost its momentum... Read more »

Tesla Inc Stock Is a ‘Sell’ Now, But Don’t Give Up Hope

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] Tesla Inc Stock Is a ‘Sell’ Now, But Don’t Give Up Hope Tesla’s stock price faces pressure from auto production figures [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]Throughout the time that I’ve been covering Tesla... Read more »

The J C Penney Company Inc Stock Story Is Bound to Get Uglier Even at $2.70, JCP stock is overvalued

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] The J C Penney Company Inc Stock Story Is Bound to Get Uglier Even at $2.70, JCP stock is overvalued [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]J C Penney Company Inc (NYSE:JCP) continues to stand... Read more »

Investors would be wise to avoid $UA stock until it hits rock bottom

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] Under Armor Inc Deserves Its Rock-Bottom Valuation Investors would be wise to avoid UA stock until it hits rock bottom [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]Ghosts and goblins weren’t the only things scaring... Read more »

Don’t Buy Twitter Inc Stock for This Simple Reason

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] Don’t Buy Twitter Inc Stock for This Simple Reason Twitter can’t defend its business model and investors shouldn’t buy it [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]The recent earnings surprise at Twitter Inc. (NASDAQ:TWTR) (it almost... Read more »

Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From Phase 3 Study of Auryxia® (Ferric Citrate) in Adults With Iron Deficiency Anemia and Non-dialysis Dependent Chronic Kidney Disease

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From Phase 3 Study of Auryxia® (Ferric Citrate) in Adults With Iron Deficiency Anemia and Non-dialysis Dependent Chronic Kidney Disease [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]... Read more »

Investors Alertness: Valeant Pharmaceuticals International, Inc. (VRX) Oversold

[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”] Investors Alertness: Valeant Pharmaceuticals International, Inc. (VRX) Oversold [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]Valeant Pharmaceuticals International, Inc. (VRX) stock go down so far this year; showing a decline of -17.84% and dropped with negative flow... Read more »